USE OF RECOMBINANT ONCOLYTIC TYPE II HERPES SIMPLEX VIRUS IN PREPARATION OF ANTI-LYMPHOMA, ESOPHAGEAL CANCER, BREAST CANCER AND PANCREATIC CANCER DRUGS

摘要

Disclosed is the use of a recombinant oncolytic type II herpes simplex virus in the preparation of anti-lymphoma, esophageal cancer, breast cancer and pancreatic cancer drugs. The recombinant oncolytic type II herpes simplex virus can specifically select to grow and reproduce in human tumour cells without affecting the proliferation of normal cells.